Agilent Technologies (NYSE:A) posted its quarterly earnings data on Wednesday. The medical research company reported $0.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.58 by $0.08, Bloomberg Earnings reports. The company had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.16 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. During the same period in the prior year, the business posted $0.53 earnings per share. Agilent Technologies updated its Q2 guidance to $0.61-0.63 EPS and its FY18 guidance to $2.62-2.68 EPS.
Shares of Agilent Technologies (NYSE:A) traded up $2.77 during midday trading on Thursday, hitting $72.47. 1,998,203 shares of the stock were exchanged, compared to its average volume of 2,196,965. The firm has a market capitalization of $22,054.50, a PE ratio of 34.20, a price-to-earnings-growth ratio of 2.06 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.30 and a quick ratio of 2.85. Agilent Technologies has a 1-year low of $50.56 and a 1-year high of $75.00.
In related news, CEO Michael R. Mcmullen sold 22,481 shares of the firm’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $68.77, for a total transaction of $1,546,018.37. Following the completion of the sale, the chief executive officer now directly owns 336,637 shares in the company, valued at $23,150,526.49. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Michael R. Mcmullen sold 21,850 shares of the firm’s stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the sale, the chief executive officer now owns 324,687 shares of the company’s stock, valued at $24,351,525. The disclosure for this sale can be found here. Insiders sold 219,991 shares of company stock valued at $15,468,795 over the last quarter.
ILLEGAL ACTIVITY NOTICE: “Agilent Technologies (A) Issues Earnings Results, Beats Expectations By $0.08 EPS” was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2018/02/15/agilent-technologies-a-issues-earnings-results-beats-expectations-by-0-08-eps.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.